Back

The REBOARREST Trial, a randomized controlled trial on aortic occlusion during cardiac arrest

31 August 2025 (11:45 - 12:00)
Organised by: Logo
Congress Presentation Part of: Late Breaking Clinical Science: optimal management of cardiogenic shock Cardiac Arrest ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Jostein Brede

St Olavs Hospital (Trondheim university hospital), Trondheim (Norway)

3 More presentations in this session

Presentation thumbnail
Age Analysis of the MCS in CS Meta Analysis
Professor U. Zeymer (Ludwigshafen, DE)
Slides Video
Presentation thumbnail
Long-term Outcomes of the DanGer Shock Trial
Professor J. Moller (Copenhagen, DK)
Slides Video
Presentation thumbnail
Centralization of CS care and MCS use
Doctor B. Schrage (Hamburg, DE)
Slides Video

Access the full session

Session thumbnail
Late Breaking Clinical Science: optimal management of cardiogenic shock
Video

The Event

Event poster

ESC Congress 2025

31 August 2025 11:45 CET
You may be interested in
thumbnail
Congress Session
Smaller trials, trial updates, and other studies: devices, cardiac arrest and atrial fibrillation ablation
thumbnail
Congress Session
Early management of out-of-hospital cardiac arrest
thumbnail
Congress Session
Late Breaking Clinical Science: optimal management of cardiogenic shock

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources